Covid-19 vaccination campaign - Informations

At Red Cross site, free parkings are avaiable, in the place and along the public way.

How to reach the site:

  • · by car: via della Croce Rossa is located near "Centro Commerciale Giotto", "Mediaworld" and "Decathlon". It is easily reachable from the motorway's exit of Padova Est. following the direction to "Padova Centro"
  • · by bus: take lines 7 or 10 (APS Holding)
  • · by train: you are requested to get off the train at the central station of Padova and to take lines 7 or 10 of the public city bus.

WARNING: to be on time is fundamental, in order to guarantee the correct administration of vaccine and to avoid gatherings.


  • · your ID
  • ·  a pen
  • · the 3 modules, that you'll find in your personal page.

You are requested to fill the modules before the appointement but to sign them only during the conversation with medical staff, in the place of the appointment.

Please, wear outfits suitable to discover easily your shoulder.

Only for technical and administrative staff: if the apponitment is scheduled during your typical work schedule, you can type the exit code "001". If the appointment is scheduled during smart working or remote working time, or when you are not working, no exit code is requested.

For the second dose of vaccine, you will be contacted according to the rules established by medical protocols.

Notification Covid Vaccine  (May 11, 2021)

Dear All,

The University vaccination campaign will resume from 24 to 28 May and from 7 to 11 June 2021. In the next few days, you will receive a personal communication with specific instructions regarding the conduct of the second phase.

The organisation of the administrations will be carried out in collaboration with the Red Cross of Padua, with the following indications to be taken into account:

a) those who have never tested positive for Covid-19 will receive the second vaccination dose and at the same time will be able to collect their final vaccination certificate on site. The time and date of the appointment will be available in the invitation email, and this date will replace any previous communication received when the first dose was administered.

b) those who tested positive for Covid-19 with the date of the first positive molecular swab before 180 days from the date of administration of the 1st dose will receive the 2nd vaccine dose and at the same time will be able to collect their final vaccination certificate on site. The time and date of the appointment will be available in the convocation email, and this date will be deemed to replace any previous communication received during the administration of the 1st dose.

c) those who have tested positive for Covid-19 with the date of the first positive molecular swab no more than 180 days after the date of administration of the 1st dose and who have already received the 1st vaccine dose during the first phase of the University Campaign will not receive the administration of a 2nd dose, as this is not foreseen by the health indications. The University Preventive Medicine Service will be responsible for sending the final vaccination certificate by email;

d) participants in the University vaccination campaign who have not received the first dose because they have tested positive for Covid-19 (with the date of the first positive molecular swab between 90 and 180 days before the scheduled date of the vaccination appointment) will only receive the first dose of vaccine and at the same time can collect their final vaccination certificate on site. At the vaccination appointment, the doctor will assess the patient's medical history and compatibility with the proposed vaccine.

e) Participants in the University Vaccination Campaign who have recently tested positive for Covid-19 (if not included in the previous points) or who did not receive their first vaccine dose during the first phase of the Campaign may join their health care region’s vaccination programme.


- It is necessary to respect the day and time that will be assigned for the administration of the vaccine. Only in the event of circumstances beyond your control that make it impossible for you to attend your scheduled appointment will you be entitled to cancel it and reschedule using the computerised procedure, subject to available slots and in any case within the deadlines set by the University's vaccination campaign.

- In order to facilitate the organisation of your appointment, we ask you to scrupulously follow the instructions that will be provided to you in a subsequent personal communication, including the possible presentation of health documentation.

Finally, we would like to remind you that, as agreed with the regional health system, the University vaccination campaign will end on 11 June 2021 and that no new openings are planned. Consequently, you will need to contact the regional health service after that date.

Kindest regards,
The Coordinating Physician
Prof. Angelo Moretto

Notification as of February 27, 2021

Covid Vaccine

Dear All,

Yesterday the Veneto Region authorized the start of the Covid-19 vaccination campaign for the University of Padua staff using the AstraZeneca vaccine.

Following the guidelines of the Region, please note:

1) The University of Padua will independently organize the vaccination of staff, in collaboration with the Preventive Medicine Service, the Departments of the Medical area, the School of Medicine and Surgery, and the Italian Red Cross (Padua branch) - a partner in this initiative. These structures will ensure the necessary medical and nursing staff needed to carry out this campaign.

2) The total number of vaccinations required by the University has already been communicated to the Veneto Region by protocol no. 24421 dated February 17, which identified a total of 9,443 people. This initiative does not include medical staff, who have already been included in the vaccination campaigns of their respective health facilities.

3) The vaccinations will be carried out in collaboration with the Red Cross, at their premises located in via della Croce Rossa, Padua. When fully operational, approximately 800 vaccinations a day will be administered. The operating procedures are currently being finalised. 

4) In keeping with the progressive availability of vaccine doses, we will adopt the following priority order:

a) members of staff actively engaged in classroom or workshop activities, in the physical presence of students, during 2020/2021 A.Y courses scheduled from March onwards (the information will be retrieved from the university's teaching and training programme software);

b) other members of staff actively engaged in lectures or workshops in the classroom, with the physical presence of the students, not included in this software, whose names will be communicated by structure managers;

c) members of staff in active service, aged 50 or over (for those over 65 we trust the Region will supply vaccine compatible with the age-group);

d) remaining staff in active service (including research fellows);

e) PhD students, non-medical postgraduates enrolled in specialization degrees, and collaborators.

In order to implement the programme as quickly and effectively as possible, we have chosen to proceed immediately by means of volunteer online registration with the vaccination programme. The link will be sent to you by today 27 February from the email address vaccinazioni@unipd.itIn this first phase it will be possible to register for vaccination until 2 pm on Tuesday, 2 March. The online registration procedure contains further instructions and information, and a consent form for the use of data. This information and consent are required in order to proceed with the vaccination. Once registered in the programme, you will be provided the necessary instructions to receive the vaccination, in compliance with the priorities set out in point 4 above and the availability of vaccine provided by the Veneto Region. 

Please note that once appointments have been scheduled they cannot be changed or modified. I am sure that you understand the reasons for this constraint, which is necessary in order to make the most of the precious doses of vaccine and to avoid delays in the roll-out of the vaccination schedule.

I would like to take this opportunity to send my best regards,

Rosario Rizzuto

Notification Covid Vaccine AstraZeneca (March 12, 2021)

Dear all,
It is our responsibility to inform you that on March 11, 2021, we received notice from AIFA of the precautionary withdrawal of lot batch ABV2856 of the AstraZeneca vaccine. 

The withdrawal was ordered after the reporting of adverse effects associated with the administration of doses belonging to the specific ABV2856 lot. There are no current links established between the administration of the vaccine and the reported adverse effects.

This specific lot was used prior to the AIFA notification and has been used for the COVID-19 vaccination campaign in the city of Padua, including doses administered through of University vaccination campaign.  The University began using this specific batch on March 4 with up to 20 vaccinated, the University began using a separate batch on March 11. Those administered with the vaccination have received a vaccination certificate with the lot number indicated on it.

A total of 3256 people were vaccinated with lot batch ABV2856, and to date, no adverse effects of any serious nature have been observed or reported. As was expected, only a few reports of modest reactions (tenderness at the injection site, fever, etc.) were reported. The Veneto Region also reported that a total of 17043 doses of the batch in question were administered in Veneto without reporting any significant adverse reactions.

The vaccination campaign will continue in the coming days as is planned.

Should we receive further communications from AIFA, the Ministry of Health, or the Region that provides for particular health surveillance measures, you will receive the relevant communication.  

Medical Coordinator
Prof. Angelo Moretto

Temporary suspension of AstraZeneca vaccinations (March 15, 2021)

Dear all,

It is our responsibility to inform you that on March 15, 2021, due to the city of Biella’s removal of AstraZeneca vaccine lot batch ABV5811, the Veneto Region is hereby suspending the use of lot batch ABV5811. 

This specific lot was still in use between March 11 and March 15, as part of the University's vaccination campaign. As of this morning, the vaccination has stopped. Currently, there are no reports of serious adverse effects in vaccinated subjects.

As a precaution, the Italian Medicines Agency (AIFA) has just issued a press release (no. 637) extending the ban of the AstraZeneca Covid 19 vaccine throughout Italy.

The decision was taken in line with similar measures adopted by other European countries. The AIFA press release also specifies that it will disclose further information as it becomes available, including additional methods of completing the vaccination cycle for those who received their first dose.

Consequently, the vaccination campaign with the AstraZeneca Covid 19 vaccine is temporarily suspended.

Following any decisions by AIFA and the related health authorities, as well as the availability of the vaccine by the Italian Red Cross facilities, those who signed up for the campaign but who have not yet been vaccinated, will receive notification regarding the restart of the campaign as soon as possible. 

Medical Coordinator
Prof. Angelo Moretto

 Resuming the AstraZeneca Vaccine Campaign (March 19, 2021) 

Dear all,
We are informing you of the results from yesterday’s Italian Medicines Agency (AIFA) press release no. 638, which states:

“Recommendations resulting from the meeting on March 18, 2021, of the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA), confirms the favorable benefit/risk balance assessment of the COVID-19 Vaccine AstraZeneca. Results from the meeting exclude the association between cases of thrombosis (blood clots) and the COVID19 vaccine. The Committee has also ruled out, based on available data, problems related to the quality and production of the vaccine.

As such, the Italian Minister of Health, the Italian Directorate General for Prevention and the Superior Health Council, and the Italian Medicines Agency states that the precautionary ban of vaccine lots that was issued on March 15, 2021, is hereby revoked. Therefore, as of today, Friday, March 19, 2021, judgments by the Committee for Medicinal Products for Human Use (CHMP) confirms that the AIFA will proceed with the use of the COVID-19 Vaccine AstraZeneca, thus allowing a complete resumption of the vaccination campaign as of 15:00 (3 pm).” 

The University Padua AstraZeneca vaccination campaign will resume on Monday, March 22 ending on Tuesday, March 23 for personnel who had a scheduled appointment but who were not been able to vaccinate due to the AIFA suspension.

 We confirm, that as of today, there have been no reports of serious adverse reactions in the approximately 5400 vaccinated subjects. As was expected, there were a few reports of non-serious reactions such as; pain around the injection site, fever, and general discomfort, etc. 

An online questionnaire will be sent to each vaccinated person in an effort to report any symptoms or disorders that have appeared in subjects after the vaccine’s administration, please be sure to fill out this questionnaire as soon as possible, all data will remain anonymous for statistical purposes. 

Please note that the completed questionnaire must be printed and brought with you before the administration of your second vaccine dose which is scheduled to take place on or around the last week of May. 

Best regards,
Medical Coordinator
Prof. Angelo Moretto